Pliant Therapeutics Q2 Net Income USD -22.371 Million
PLRX•Q2 results
Aug. 11 (Reuters) - Pliant Therapeutics Q2 operating expenses were USD -23.862 million.
- Q2 operating income was USD -23.862 million.
PLRX•Aug. 11 (Reuters) - Pliant Therapeutics Q2 operating expenses were USD -23.862 million.